Evidence map›Paper›PMID 39963256›Full record

ArticleFrontiers in pediatrics2024

Prevalence of myopia and refractive parameters among children and adolescents in Hi-tech District of Chengdu City.

Xiaoqin Wang, Liuzhi Zeng, Yiping Xian, Mei Xin, Qingqing Shan, Weiye Li, Lixia Lv, Yifeng Liu, Rui Zhang, Kejian Song and 9 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xiaoqin WangDepartment of Ophthalmology, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Liuzhi ZengDepartment of Ophthalmology, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Yiping XianDepartment of Ophthalmology, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Mei XinDepartment of Ophthalmology, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Qingqing ShanDepartment of Respiration, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Weiye LiDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Lixia LvDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Yifeng LiuDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Rui ZhangDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Kejian SongDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Xixi TianDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Han GuoHigh-tech Zone Healthcare Development Center, Chengdu, Sichuan, China.
Changjiang YanHigh-tech Zone Education Development Center, Chengdu, Sichuan, China.
Chunyan LiHigh-tech Zone Zhonghe Primary School, Chengdu, Sichuan, China.
Xueni LuoDepartment of Ophthalmology, High-Tech Zone Zhonghe Community Health Service Center, Chengdu, Sichuan, China.
Honglin LuoDepartment of Ophthalmology, High-Tech Zone Zhonghe Community Health Service Center, Chengdu, Sichuan, China.
Ling YangHigh-tech Zone Healthcare Development Center, Chengdu, Sichuan, China.
Jun LuoDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
Zejun ChenDevelopment Department, Chengdu First People's Hospital/Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the prevalence of myopia among children and adolescents in Chengdu from 2021 to 2023, providing insights for myopia prevention and control. Methods: This study was a school-based cross-sectional study in children and adolescents aged 3-18 years in Hi-tech District of Chengdu City. All the students underwent comprehensive ocular measurement, including uncorrected binocular visual acuity (VA), spherical equivalent error (SER) with noncycloplegic autorefraction, corneal radius (CR), and axial length (AL). Results: Over the three-year study period from 2021 to 2023, the overall prevalence of myopia was 38.15%, with annual rates of 38.74% in 2021, 38.67% in 2022, and 37.03% in 2023. The prevalence and severity of myopia increased significantly with age ( Conclusion: Myopic prevalence among children and adolescents in Hi-tech District of Chengdu City decreased from 2021 to 2023. The prevalence increased with age and school level, indicating a need for targeted interventions. Significant changes in spherical equivalent refraction and AL emphasize the importance of early intervention and regular monitoring of myopia for an effective management.

Indexed as

axial lengthepidemiologicalmyopiaprevalencespherical equivalent error

Identifiers

PMID39963256
PMCPMC11830511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.